The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBruntwood Bd 6% Regulatory News (BRU2)

Share Price Information for Bruntwood Bd 6% (BRU2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.55
Bid: 98.10
Ask: 99.00
Change: 0.00 (0.00%)
Spread: 0.90 (0.917%)
Open: 98.55
High: 0.00
Low: 0.00
Prev. Close: 98.55
BRU2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

6 Feb 2023 08:00

RNS Number : 7770O
Bruntwood Bond 2 PLC
06 February 2023
 

6th February 2023

BRUNTWOOD GROUP LIMITED

BRUNTWOOD INVESTMENTS PLC

BRUNTWOOD BOND 2 PLC

 

UPDATE STATEMENT ON 2022 ANNUAL RESULTS

Bruntwood Group Limited ("Bruntwood") today updates the market on the recent publication of the 2022 financial statements and a summary of the latest rent collection position.

Across the group, net asset value rose by more than 10% to £671.5m (2021: £606.5m) and the value of its combined portfolio, including Bruntwood SciTech assets and other joint ventures reached £2.0bn (2021: £1.8bn). 

 

Chris Oglesby, CEO of Bruntwood, said

"We have aligned our products and proposition with the businesses and organisations driving the future of the UK economy in innovation-linked sectors like tech and digital, life sciences and their supporting ecosystems, all of which continue to show huge potential in many of our regional cities. 

 

"As we now lean into the challenges presented by the end of another economic cycle, this will remain our focus. We will continue to focus our energies on investing in assets, whether that's for Bruntwood SciTech or Works, in such a way that meets the needs of modern business and industry, targeting growth into new and existing cities around the UK."

 

Bruntwood made a number of significant investments and acquisitions that contributed to this growth, while market sentiment towards science and technology real estate assets strengthened. 

 

Within the Bruntwood SciTech portfolio, it unveiled a £76.2m investment into the purchase and regeneration of Glasgow's famous Met Tower, to create a new tech and digital campus and marking Bruntwood and Bruntwood SciTech's first development in Scotland.

 

Within the Bruntwood Works portfolio, it completed the £3m refurbishment of Liverpool's The Plaza, gained approval for the net zero redevelopment of Manchester's Grade II listed Pall Mall and work started on the 90,000 sq ft Castle House in Leeds as part of the wider West Village regeneration project.

 

Financial Position

The Group filed its annual accounts for the year ending September 30th 2022. Key highlights include:

· Reported pre-tax profit of £75.2m (2021: £44.9m) - the second-best results in the group's 46-years of trading 

· Net asset value increases of 10.7% (£671.5m) and total assets under management hits £2.0bn (2021: £1.8bn)

· Further investment of £147m of capital, realised revaluation gains of £153m and non-core disposals of £72m. 

 

The full financial statements can be found at: 

https://bruntwood.co.uk/our-performance/disclaimer/retail-bond-2025/

The Group's liquidity position has also improved. As of 31st January 2023, the Group has £16m of cash reserves (10 January 2022: £9.2m), £40m of undrawn committed available facilities (10 January 2022: £28m) and £70m (10 January 2022: £71m) of unencumbered assets upon which further finance could be secured.

The 2025 bond covenants have been tested as at September 2022 and are met with significant headroom. The covenant testing and compliance certificate can be found on the Bruntwood website (link as above). 

At the same time, given the challenging economic outlook, the Board has increased its stress testing and the consideration of various scenarios including reviewing estimated customer default rates, lower retention rates, higher concessions and valuation yield movement. Based on the output of these models, the Board considers there to be sufficient income and valuation headroom across Bruntwood's debt facilities and does not expect Bruntwood to breach any terms relating to them. We have modelled the forecast covenant performance on each loan facility. Valuation covenant headroom is in excess of 30% on all of our facilities. 

Nevertheless, due to the rise in interest rates, the Group has negotiated less onerous Interest Cover (ICR) covenants on its main debt facility to help support the business for the future. 

Impact on Operations

As of 27th January 2022, 93% of December quarter rents had been collected. This is comparable to the September / June quarters at the same point and ahead of the prior year comparative. 

ENDS

For further information, please see Bruntwood's website at https://bruntwood.co.uk/or contact:

 

Kevin Crotty (Chief Financial Officer)

+44 (0) 161 212 2222

Sean Davies (Director of Financing & Investment)

Patrick King, Mark Truman (WH Ireland Capital Markets)

Mark Glowrey (Allia C&C)

 

+44 (0) 161 212 2222

+44 (0) 207 220 1666

 

+44 (0) 203 039 3465

Forward-Looking Statements: This announcement contains certain forward-looking statements with respect to Bruntwood's expectations and plans, strategy, management objectives, future developments and performances, costs, revenues and other trend information. These statements are subject to assumptions, risk and uncertainty. Many of these assumptions, risks and uncertainties relate to factors that are beyond Bruntwood's ability to control or estimate precisely and which could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Certain statements have been made with reference to forecast process changes, economic conditions and the current regulatory environment. Any forward-looking statements made by or on behalf of Bruntwood are based upon the knowledge and information available to Directors on the date of this announcement. Accordingly, no assurance can be given that any particular expectation will be met and Bruntwood's bondholders are cautioned not to place undue reliance on the forward-looking statements. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Other than in accordance with its legal or regulatory obligations (including under the UK Listing Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority), Bruntwood does not undertake to update forward-looking statements to reflect any changes in events, conditions or circumstances on which any such statement is based. Past bond performance cannot be relied on as a guide to future performance. Nothing in this announcement should be construed as a profit forecast. The information in this announcement does not constitute an offer to sell or an invitation to buy securities in Bruntwood or an invitation or inducement to engage in any other investment activities.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSSDFDEEDSEIE
Date   Source Headline
2nd Feb 20248:00 amRNSAnnual Financial Report
16th Oct 20238:00 amRNSEquity investment into Bruntwood Scitech Ltd
6th Feb 20238:00 amRNSAnnual Financial Report
1st Feb 20228:00 amRNS2021 Annual Financial Results
25th Oct 20218:00 amRNSOctober performance update
21st Jul 20218:00 amRNSJune 21 Quarterly Rent Update
26th Apr 20218:00 amRNSMarch 21 quarterly rent update
29th Jan 20218:00 amRNSUpdate on Covid rent collection and annual results
23rd Oct 20208:00 amRNSUpdate statement on Covid 19 and rent collection
24th Jul 20208:32 amRNSUpdate Statement on Covid 19 and Rent Collection
15th Apr 20208:18 amRNSBruntwood statement re Covid-19
18th Feb 20203:50 pmRNSBruntwood Bond 2 PLC sizing announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.